XML 23 R12.htm IDEA: XBRL DOCUMENT v3.20.2
Stock-Based Compensation and Shareholders' Equity
9 Months Ended
Aug. 01, 2020
Share-based Payment Arrangement [Abstract]  
Stock-Based Compensation and Shareholders' Equity Stock-Based Compensation and Shareholders' Equity
A summary of the Company’s stock option activity as of August 1, 2020 and changes during the nine-month period then ended is presented below:
Options
Outstanding
(in thousands)
Weighted-
Average Exercise
Price Per Share
Weighted-
Average
Remaining
Contractual
Term in Years
Aggregate
Intrinsic
Value
Options outstanding at November 2, 20195,183 $65.97 
Options granted359 $94.41 
Options exercised(1,032)$55.96 
Options forfeited(97)$84.27 
Options outstanding at August 1, 20204,413 $70.18 5.73$197,106 
Options exercisable at August 1, 20202,845 $60.81 4.66$153,749 
Options vested or expected to vest at August 1, 2020 (1)4,309 $69.67 5.67$194,685 
(1) In addition to the vested options, the Company expects a portion of the unvested options to vest at some point in the future. The number of options expected to vest is calculated by applying an estimated forfeiture rate to the unvested options.
During the nine-month periods ended August 1, 2020 and August 3, 2019, the total intrinsic value of options exercised (i.e., the difference between the market price at exercise and the price paid by the employee to exercise the options) was $61.7 million and $120.7 million, respectively.
A summary of the Company’s restricted stock unit/award activity as of August 1, 2020 and changes during the nine-month period then ended is presented below: 
Restricted
Stock Units/Awards
Outstanding
(in thousands)
Weighted-
Average Grant-
Date Fair Value
Per Share
Restricted stock units/awards outstanding at November 2, 20194,396 $87.18 
Units/Awards granted1,390 $92.00 
Restrictions lapsed(1,691)$86.51 
Forfeited(196)$88.86 
Restricted stock units/awards outstanding at August 1, 20203,899 $89.65 
As of August 1, 2020, there was $316.0 million of total unrecognized compensation cost related to unvested stock-based awards comprised of stock options and restricted stock units/awards. That cost is expected to be recognized over a weighted-average period of 1.4 years. The total grant-date fair values of awards that vested during the nine-month periods ended August 1, 2020 and August 3, 2019 were approximately $157.9 million and $131.0 million, respectively.

Total stock-based compensation expense recognized was as follows:
Three Months EndedNine Months Ended
August 1, 2020August 3, 2019August 1, 2020August 3, 2019
Cost of sales$4,508 $5,247 $13,428 $15,720 
Research and development19,158 18,802 55,163 57,294 
Selling, marketing, general and administrative14,951 12,049 43,427 39,706 
Special charges943 — 943 — 
Total stock-based compensation expense$39,560 $36,098 $112,961 $112,720 

As of August 1, 2020 and November 2, 2019, the Company capitalized $5.9 million and $6.8 million, respectively, of stock-based compensation in Inventories on the Condensed Consolidated Balance Sheets.
Common Stock Repurchases
As of August 1, 2020, the Company had repurchased a total of approximately 156.1 million shares of its common stock for approximately $6.3 billion under the Company's share repurchase program. As of August 1, 2020, an additional $1.9 billion remains available for repurchase of shares under the current authorized program. The Company also repurchases shares in settlement of employee tax withholding obligations due upon the vesting of restricted stock units/awards or the exercise of stock options. Given the planned acquisition of Maxim (see Note 15, Acquisitions), the Company has continued its temporary suspension of the common stock repurchase program, which was previously suspended in March 2020 as a result of the global macroeconomic environment. Future repurchases of common stock will be dependent upon the Company's financial position, results of operations, outlook, liquidity, and other factors deemed relevant by the Company.
Analog Devices Foundation
During the first quarter of fiscal 2020, the Company contributed 335,654 shares of its common stock to the Analog Devices Foundation. As of the date of the charitable contribution the shares had a fair value of approximately $40.0 million. This expense was recorded in Selling, marketing, general and administrative expense in the Condensed Consolidated Statement of Income.